ArticleBone marrow transplantation2024

Persistent IDH mutations are not associated with increased relapse or death in patients with IDH-mutated acute myeloid leukemia undergoing allogeneic hematopoietic cell transplant with post-transplant cyclophosphamide.

Niveditha Ravindra et al.PubMed ↗Publisher ↗

No numbers read from the abstract.